Smith & Nephew (SNN) Return on Capital Employed (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Return on Capital Employed of 12.16% for Q4 2024, up 4545.0% year-on-year from 0.26% in Q1 2024, and up 136.52% on a QoQ basis from 33.29% in Q4 2023.
Smith & Nephew (SNN) Return on Capital Employed (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Return on Capital Employed for 14 consecutive years, with 12.16% the latest figure, recorded in Q4 2024.
- Quarterly Return on Capital Employed rose 4545.0% year-over-year to 12.16% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 12.16% (up 4545.0% YoY) and the FY2025 annual result came in at 9.01%, down 896.0% from the prior year.
- Return on Capital Employed improved to 12.16% in Q4 2024 per SNN's latest filing, from 33.29% in the prior quarter.
- Over the last five years, Return on Capital Employed for SNN reached as high as 38.89% in Q4 2020 and fell as low as 52.68% in Q4 2022.
- A 5-year average of 16.67% and a median of 33.29% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2021 — Return on Capital Employed tumbled 8731 bps — and 2024, when it surged 4545 bps.
- Year by year, Return on Capital Employed stood at 38.89% in 2020, then sank by 225 bps to 48.43% in 2021, then declined by 9 bps to 52.68% in 2022, then soared by 37 bps to 33.29% in 2023, then surged by 137 bps to 12.16% in 2024.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 12.16%, 33.29%, and 52.68% for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 11.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.16% |
| Dec 31, 2023 | -33.29% |
| Dec 31, 2022 | -52.68% |
| Dec 31, 2021 | -48.43% |
| Dec 31, 2020 | 38.89% |
| Dec 31, 2019 | 53.63% |
| Dec 31, 2018 | 65.68% |
| Dec 31, 2017 | 67.32% |
| Dec 31, 2016 | 22.33% |
| Dec 31, 2015 | 20.32% |
| Dec 31, 2014 | 15.14% |
| Mar 31, 2014 | 18.28% |
| Dec 31, 2013 | 19.22% |
| Mar 31, 2013 | 19.28% |
| Dec 31, 2012 | 34.65% |
| Jun 30, 2012 | 35.37% |
| Mar 31, 2012 | 78.90% |
| Dec 31, 2009 | 18.56% |
| Sep 30, 2009 | 29.22% |
| Jun 30, 2009 | 7,841,481.90% |